Shu Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shu Yang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jiang Liu
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430000, China
1 shared publication - Jianmin Liu
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Junchao Zhang
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
1 shared publication - Michael. E. DiSanto
Department of Surgery and Biomedical Sciences, Cooper Medical School of Rowan University, Camden, USA
1 shared publication - Ping Chen
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China
1 shared publication - Xinhua Zhang
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China
1 shared publication
Latest Publications
- Open Access
- 2 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2870
The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a common disease in elderly men. It is characterized by prostatic enlargement and urethral compression and often causes lower urinary tract symptoms (LUTs) such as urinary frequency, urgency, and nocturia. Existing studies have shown that the pathological process of prostate hyperplasia is mainly related to the imbalance of cell proliferation and apoptosis, inflammation, epithelial–mesenchymal transition (EMT), and growth factors. However, the exact molecular mechanisms remain incompletely elucidated. Cell adhesion molecules (CAMs) are a group of cell surface proteins that mediate cell–cell adhesion and cell migration. Modulating adhesion molecule expression can regulate cell proliferation, apoptosis, EMT, and fibrotic processes, engaged in the development of prostatic hyperplasia. In this review, we went over the important roles and molecular mechanisms of cell adhesion molecules (mainly integrins and cadherins) in both physiological and pathological processes. We also analyzed the mechanisms of CAMs in prostate hyperplasia and explored the potential value of targeting CAMs as a therapeutic strategy for BPH.
- 2 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2870
Open AccessThe Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a common disease in elderly men. It is characterized by prostatic enlargement and urethral compression and often causes lower urinary tract symptoms (LUTs) such as urinary frequency, urgency, and nocturia. Existing studies have shown that the pathological process of prostate hyperplasia is mainly related to the imbalance of cell proliferation and apoptosis, inflammation, epithelial–mesenchymal transition (EMT), and growth factors. However, the exact molecular mechanisms remain incompletely elucidated. Cell adhesion molecules (CAMs) are a group of cell surface proteins that mediate cell–cell adhesion and cell migration. Modulating adhesion molecule expression can regulate cell proliferation, apoptosis, EMT, and fibrotic processes, engaged in the development of prostatic hyperplasia. In this review, we went over the important roles and molecular mechanisms of cell adhesion molecules (mainly integrins and cadherins) in both physiological and pathological processes. We also analyzed the mechanisms of CAMs in prostate hyperplasia and explored the potential value of targeting CAMs as a therapeutic strategy for BPH.